EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents

G. Schwartsmann, J. Wanders, I. J. Koier, H. R. Franklin, O. Dalesio, H. W. Hornstra, M. van Glabbeke, J. Renard, A. T. Van Oosterom, S. B. Kaye, H. M. Pinedo

Research output: Contribution to journal › Article › peer-review